1. Baulieu, E.-E., Corpechot, C., Dray, F., Emiliozzi, R., Lebeau, M.-C., Mauvais-Jarvis R. and Robel, R., An adrenal-secreted “androgen”: Dehydroisoandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man.Recent Prog. Horm. Res., 21, 411–500 (1965).
2. Butenandt, A. and Dannenbaum, H., Uber Androsteron III. Isolierung eines neuen, physiologisch unwirksamen Sterinderivates aus Mannweharn, seine Verknupfung mit Dehydro-androsteron und Androsteron: ein Beitrag zur Konstitution des Androsteron.Hoppe-Seyler's J. Physiol. Chem., 229, 192–208 (1934).
3. Gatto, V., Aragno, M., Gallo, M., Tamagno, E., Martini, A., Di Monaco, M., Brignardello, E. and Boccuzzi, G., Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor.Oncol. Rep., 5, 241–243 (1998).
4. Gordon, G. B., Shantz, L. M. and Talalay, R., Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.Adv. Enzyme Regul., 26, 355–382 (1987).
5. Kensler, T. W. and Trush, M. A., Role of oxygen radicals in tumor promotion.Environ. Mutagenesis, 6, 593–616 (1984).